Dietrich Seidel

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)

R. Muche, D. Nagel, P. Cremer, 1994, European journal of clinical investigation.

No evidence for feedback inhibition of hepatic apolipoprotein B (apo B) production after extracorporeal low density lipoprotein precipitation as determined by [I‐13C]leucine infusion in normal volunteers

V. Armstrong, D. Bier, D. Seidel, 1993, European journal of clinical investigation.

The HELP‐LDL‐apheresis multicentre study, an angiographically assessed trial on the role of LDL‐apheresis in the secondary prevention of coronary heart disease

V. Armstrong, P. Schuff-Werner, D. Seidel, 1991, European journal of clinical investigation.

Effect of HELP‐LDL‐apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post‐treatment return to baseline levels

V. Armstrong, P. Schuff-Werner, R. Muche, 1989, European journal of clinical investigation.

Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin‐induced extracorporeal LDL precipitation (HELP) *

V. Armstrong, E. Schütz, P. Schuff-Werner, 1989, European journal of clinical investigation.

Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration.

V. Armstrong, R. Muche, D. Seidel, 1988, Kidney international.